James Charles Miller - Apr 20, 2021 Form 4/A - Amendment Insider Report for Recro Pharma, Inc. (SCTL)

Role
Director
Signature
/s/ Ryan D. Lake, attorney-in-fact
Stock symbol
SCTL
Transactions as of
Apr 20, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/17/2021, 04:05 PM
Date Of Original Report
Apr 22, 2021
Next filing
Nov 19, 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amended Form 4 is being filed to correct a typographical error in the exercise price of the stock options acquired on April 20, 2021 as reported on the Form 4 filed on April 22, 2021.
F2 The stock option will vest on April 20, 2022.